---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-036862"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2024-12-06T23:59:59+00:00"
generated_at: "2026-05-29T06:34:48.683443+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences CEO Barrett resigns; Danahy, Uecker named interim executives

## Summary
- CEO Burke T. Barrett resigns effective Dec 6, 2024; also leaves board Dec 2, 2024.
- Resignation not due to any disagreement; company affirms development and clinical plans on track.
- Severance: 12 months base salary (24 installments), $106,009.61 bonus, partial vesting of 101,000 options at $7.45, COBRA.
- Chief Commercial Officer Kevin Danahy and CTO Darrin Uecker serve as interim principal executive and financial officers.

## SEC filing metadata
- accession: 0001437749-24-036862
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2024-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774924036862/0001437749-24-036862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774924036862/plse20241206c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-036862
- JSON: https://secwatch.observer/filing/0001437749-24-036862.json
- Plain text: https://secwatch.observer/filing/0001437749-24-036862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.